Recombinant multi-species GSTA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GSTA1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of a family of enzymes that function to add glutathione to target electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins, and products of oxidative stress. This action is an important step in detoxification of these compounds. This subfamily of enzymes has a particular role in protecting cells from reactive oxygen species and the products of peroxidation. Polymorphisms in this gene influence the ability of individuals to metabolize different drugs. This gene is located in a cluster of similar genes and pseudogenes on chromosome 6. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
The Alternative Names of target: GSTA1,Glutathione S-transferase A1,13-hydroperoxyoctadecadienoate peroxidase, Androst-5-ene-3,17-dione isomerase, GST HA subunit 1, GST class-alpha member 1, GST-epsilon, GSTA1-1, GTH1,GST2,GTH1,GSTA1-1,GST-epsilon

Target products collectionGo to GSTA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T17221-Ab-1/ GM-Tg-hg-T17221-Ab-2 Human GSTA1 protein Human
GM-Tg-rg-T17221-Ab-1/ GM-Tg-rg-T17221-Ab-2 Rat GSTA1 protein Rat
GM-Tg-mg-T17221-Ab-1/ GM-Tg-mg-T17221-Ab-2 Mouse GSTA1 protein Mouse
GM-Tg-cynog-T17221-Ab-1/ GM-Tg-cynog-T17221-Ab-2 Cynomolgus/Rhesus macaque GSTA1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T17221-Ab-1/ GM-Tg-felg-T17221-Ab-2 Feline GSTA1 protein Feline
GM-Tg-cang-T17221-Ab-1/ GM-Tg-cang-T17221-Ab-2 Canine GSTA1 protein Canine
GM-Tg-bovg-T17221-Ab-1/ GM-Tg-bovg-T17221-Ab-2 Bovine GSTA1 protein Bovine
GM-Tg-equg-T17221-Ab-1/ GM-Tg-equg-T17221-Ab-2 Equine GSTA1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T17221-Ab-1/ GM-Tg-hg-T17221-Ab-2; GM-Tg-rg-T17221-Ab-1/ GM-Tg-rg-T17221-Ab-2;
GM-Tg-mg-T17221-Ab-1/ GM-Tg-mg-T17221-Ab-2; GM-Tg-cynog-T17221-Ab-1/ GM-Tg-cynog-T17221-Ab-2;
GM-Tg-felg-T17221-Ab-1/ GM-Tg-felg-T17221-Ab-2; GM-Tg-cang-T17221-Ab-1/ GM-Tg-cang-T17221-Ab-2;
GM-Tg-bovg-T17221-Ab-1/ GM-Tg-bovg-T17221-Ab-2; GM-Tg-equg-T17221-Ab-1/ GM-Tg-equg-T17221-Ab-2
Products Name GSTA1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GSTA1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GSTA1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.